Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70

Hematologic malignancies in older people are unlikely to be cured with chemotherapy alone. Advances in allogeneic blood or marrow transplantation (alloBMT), especially nonmyeloablative (NMA) conditioning and the use of haploidentical donors, now make this therapy available to older people; however,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Adv
Egile Nagusiak: Imus, Philip H., Tsai, Hua-Ling, Luznik, Leo, Fuchs, Ephraim J., Huff, Carol Ann, Gladstone, Douglas E., Lowery, Patrick, Ambinder, Richard F., Borrello, Ivan M., Swinnen, Lode J., Wagner-Johnston, Nina, Gocke, Christian B., Ali, Syed Abbas, Bolaños-Meade, F. Javier, Varadhan, Ravi, Jones, Richard J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2019
Gaiak:
Transplantation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737415/
https://ncbi.nlm.nih.gov/pubmed/31492679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000155
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak